Latest News

May 2, 2023

Learn About SAMHSA’s Behavioral Health Equity Challenge

We wanted to share this message from SAMHSA about its Behavioral Health Equity Challenge.
March 31, 2023

SAMHSA Recommendations for Curricular Elements in Substance Use Disorders Training

SAMHSA provides information on how practitioners can meet the requirement.
White House, Washington
March 29, 2023

ONDCP: Dr. Gupta Applauds FDA Announcement to Make First Naloxone Product Available Over-the-Counter

From the Office of National Drug Control Policy: WASHINGTON, D.C. – Today, Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), issued a statement following the U.S. Food and Drug Administration (FDA) approval of the first nonprescription, “over-the-counter” (OTC) Naloxone nasal spray (Narcan). Naloxone – a medicine that can reverse an opioid-related overdose – has been shown to be a critical tool to prevent fatal overdoses and save lives.